ArticleTAG. Theoretical and applied genetics. Theoretische und angewandte Genetik2026
Genome-wide linkage and association mapping identified a novel candidate gene, TaGLK-A1, underlying fructan content in wheat grain.
Article in TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
key messageA nuclear-localized G2-like transcription factor, TaGLK-A1 (TraesCS7A02G539600), was identified as a strong candidate gene for grain fructan content in wheat using GWAS, linkage mapping and transcriptome analysis. Fructans, a type of natural polysaccharides or oligosaccharides polymerized from fructose molecules, play important physiological roles in crops and confer great health benefits to humans. In this study, we detected 78 stable loci associated with fructan content across all 21 wheat chromosomes across three environments and in the BLUE, explaining 4.4-10.0% of the phenotypic variance by a genome-wide association study (GWAS) using 243 wheat cultivars and advanced lines genotyped with the Axiom wheat 660 K single-nucleotide polymorphism (SNP) array. Among these, a significant locus of fructan content was localized in a 4.02 Mb interval (713.87-717.89 Mb) on chromosome 7AL, designated QGfc.hkd-7A. QGfc.hkd-7A was validated in 164 recombinant inbred lines (RILs) from a cross between Avocet and Chilero in five environments using diversity array technology (DArT), which was tightly linked to DArT markers SNP2260399, 3575400, SNP3028492, SNP100415949, 3533474 and 100091413, accounting for 16.4-24.6% of the total phenotypic variance in the RIL population. Favorable allele of QGfc.hkd-7A significantly increased grain fructan content by 10.5% (P < 0.01) compared with lines carrying unfavorable alleles. To further validate QGfc.hkd-7A, we generated differential gene expression profiles using RNA-seq for high-fructan (AC6012) and low-fructan (AC6361) lines from the Avocet/Chilero population. TaGLK-A1 (TraesCS7A02G539600), a differential expressed gene (DEG), was subsequently cloned and sequenced from both genotypes. Sequence comparison of the full-length TaGLK-A1 cDNA (1545 bp) revealed a single SNP at position 109 causing a proline (CCA) to threonine substitution between Avocet and Chilero. Subcellular localization analysis confirmed that the G2-like transcription factor encoded by TaGLK-A1 localizes to the nucleus. Transactivation assays revealed that it lacks intrinsic transcriptional activation activity, suggesting it may function as a transcriptional repressor or require cofactors for regulatory function. These results provide a novel and strong candidate gene for fructan content and a forward genetics strategy for gene discovery in molecular breeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.